ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08572
-0,03%
Bitcoin
70.195,48
-1,75%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Nastech Pharmaceutical Company (MM) (NSTK)

  7. Nastech Pharmaceutical Company (MM) (NSTK) News

NSTK

Nastech Pharmaceutical Company (MM) (NSTK)

Nastech Pharmaceutical Company (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NSTK
DatumZeitQuelleÜberschriftSymbolFirma
09/06/200820h31Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
09/06/200813h00Business WireNastech Announces Positive Intranasal Insulin Data at American Diabetes Association MeetingNASDAQ:NSTKNastech Pharmaceutical Company (MM)
15/05/200800h55Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
14/05/200800h13Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
12/05/200823h28Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/05/200822h05Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Quarterly Report (10-Q)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/05/200822h03Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
08/05/200822h00Business WireNastech Announces First Quarter 2008 Financial ResultsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
01/05/200822h00Business WireNastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008NASDAQ:NSTKNastech Pharmaceutical Company (MM)
30/04/200823h19Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
30/04/200823h18Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
29/04/200819h50Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
25/04/200814h00Business WireNastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct OfferingNASDAQ:NSTKNastech Pharmaceutical Company (MM)
18/04/200812h04Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
02/04/200822h53Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
02/04/200822h52Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
27/03/200813h00Business WireNastech Pharmaceutical Company Inc. Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific AdvisoryNASDAQ:NSTKNastech Pharmaceutical Company (MM)
25/03/200817h41Business WireNastech Pharmaceutical Company Inc. to Present RNAi DataNASDAQ:NSTKNastech Pharmaceutical Company (MM)
21/03/200821h00Business WireNastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
19/03/200821h47Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
19/03/200802h36Business WireWall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company (NASDAQGM: NSTK)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
17/03/200821h09Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Annual Report (10-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
17/03/200821h03Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
17/03/200821h00Business WireNastech Announces Fourth Quarter and Full Year 2007 Financial ResultsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
13/03/200813h00Business WireNastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor ForumNASDAQ:NSTKNastech Pharmaceutical Company (MM)
11/03/200813h00Business WireNastech Pharmaceutical Company Inc. Completes Key RNAi Patent FilingsNASDAQ:NSTKNastech Pharmaceutical Company (MM)
10/03/200821h17Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
07/03/200814h00Business WireNastech Pharmaceutical Company Inc. Announces Scientific Advisory Board for MDRNA, Inc., its Wholly-Owned RNAi SubsidiaryNASDAQ:NSTKNastech Pharmaceutical Company (MM)
04/03/200823h27Edgar (US Regulatory)Nastech Pharmaceutical CO Inc - Current report filing (8-K)NASDAQ:NSTKNastech Pharmaceutical Company (MM)
29/02/200820h23PR Newswire (US)Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, MaNASDAQ:NSTKNastech Pharmaceutical Company (MM)
 Showing the most relevant articles for your search:NASDAQ:NSTK

Kürzlich von Ihnen besucht

AMEX
XLE
Energy Select Sector SPDR
DBI
DAX
DAX
NASDAQ
GOOGL
Alphabet
TG
NOV
Novo Nordisk
NYSE
JPM
JP Morgan Chase
NYSE
KO
Coca Cola
FX
EURUSD
Euro vs US Dollar
PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
TG
DBK
Deutsche Bank
TG
BAYN
Bayer
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
TG
RHM
Rheinmetall
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten